Ardelyx (ARDX) EBT Margin Growth (3y) (2018 - 2026)
Ardelyx (ARDX) EBT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 19,557.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,557.00 |
| Dec 31, 2025 | -2,453.00 |
| Sep 30, 2025 | 43,365.00 |
| Jun 30, 2025 | 104,666.00 |
| Mar 31, 2025 | 594,329.00 |
| Dec 31, 2024 | 352,531.00 |
| Sep 30, 2024 | 371,499.00 |
| Jun 30, 2024 | 341,913.00 |
| Mar 31, 2024 | 44,635.00 |
| Dec 31, 2023 | 151,328.00 |
| Sep 30, 2023 | 67,956.00 |
| Jun 30, 2023 | 128,260.00 |
| Mar 31, 2023 | 160,907.00 |
| Dec 31, 2022 | 90,376.00 |
| Sep 30, 2022 | 31,211.00 |
| Jun 30, 2022 | 14.04 Mn |
| Dec 31, 2021 | 2.93 Mn |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 7.09 Mn |
| Mar 31, 2021 | 22,970.00 |